Pila Pharma is a TRPV1-platform focused company developing oral treatments for type-2 diabetes, obesity, and pain.
Pila Pharma has raised $3.2M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in October 2025.
Pila Pharma's investors include Almi Invest, EISMEA, Dorte Xenia Gram.
Pila Pharma is headquartered in Malmö, Sweden.
Pila Pharma is a TRPV1-platform focused company developing oral treatments for type-2 diabetes, obesity, and pain.
Pila Pharma is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pila Pharma — Funding & Investors." VCBacked, October 28, 2025, https://www.vcbacked.co/company/pila-pharma. Accessed July 20, 2026.
VCBacked. (2025). Pila Pharma — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/pila-pharma
{{cite web |title=Pila Pharma — Funding & Investors |url=https://www.vcbacked.co/company/pila-pharma |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated